Obesity, defined as having a body mass index of ≥30 kg/m², has been a major public health crisis for decades. In the U.S. alone, 20% of children and 40% of adults are obese, costing the U.S. healthcare system billions annually.

Obesity causes or exacerbates over 200 medical disorders, including immune-mediated inflammatory diseases (IMIDs), such as psoriasis, psoriatic arthritis, and inflammatory bowel disease. Thus, it is imperative for clinicians and patients to understand the importance of obesity and its relationship to IMIDs, and to manage both conditions in tandem.

Our FLOURISH+ website and educational activity program is a comprehensive, multi-specialty initiative aimed at providing clinicians and patients with up-to-date information on the immunopathologic factors linking obesity with IMIDs, the latest clinical trial updates on treatments for these bidirectional conditions, and multidisciplinary management strategies for optimal patient outcomes.